GSK is investing $110 million to partner with Relation Therapeutics, aiming to generate high-quality cellular data for AI model training. This collaboration signifies a shift in the industry away from massive datasets towards more precise biological research, which is expected to accelerate drug discovery. AI
IMPACT This partnership signals a move towards more targeted data generation for AI in drug discovery, potentially accelerating the development of new therapies.
RANK_REASON Significant funding round for AI-driven drug discovery. [lever_c_demoted from significant: ic=1 ai=0.7]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
